RiteMED Terazosin Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Terazosin HCl dihydrate

Indications/Uses

Mild to moderate HTN. Symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia (BPH).

Click to view RiteMED Terazosin detailed prescribing information

Dosage/Direction for Use

Adult HTN Initially 1 mg before bedtime. Maintenance: 2 mg daily. Max of 20 mg. Symptomatic treatment of urinary obstruction caused by BPH Initially 1 mg at night-time for 7 days, can be increased to 2 mg daily for 14 days, followed by 5 mg daily for 7 days. Usual dose: 5 mg once daily. Max of 10 mg.

Click to view RiteMED Terazosin detailed prescribing information

Overdosage

View RiteMED Terazosin overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Swallow whole, do not chew.

Contraindications

Hypersensitivity to terazosin or to a structurally similar α-adrenergic antagonist.

Click to view RiteMED Terazosin detailed prescribing information

Special Precautions

History of micturition syncope. Concomitant use w/ PDE-5 inhibitors. Risk of intraoperative floppy iris syndrome. Patients w/ pulmonary edema due to aortic or mitral stenosis, high-output cardiac insufficiency, right-ventricular heart failure caused by pulmonary embolism or pericardial effusion, left-ventricular heart failure w/ low filling pressure. May affect ability to drive or operate machinery. Renal & hepatic impairment. Elderly. Childn. Pregnancy & lactation.

Click to view RiteMED Terazosin detailed prescribing information

Use In Pregnancy & Lactation

Click to view RiteMED Terazosin detailed prescribing information

Adverse Reactions

Headache, dizziness; vertigo; asthenia. Sinusitis; nervousness; paraesthesia, somnolence; blurred vision; palpitations, tachycardia; orthostatic hypotension; dyspnoea, nasal congestion; nausea; pain in extremities, back pain; erectile dysfunction; peripheral edema, fatigue, edema in the mucosa.

Click to view RiteMED Terazosin detailed prescribing information

Drug Interactions

Hypotension w/ other antihypertensive agents. Not recommended in combination w/ α-receptor blockers. May increased hypertensive effect w/ vasodilators & nitrates. Symptomatic hypotension w/ PDE-5 inhibitors (eg, sildenafil, tadalafil & vardenafil). May reduce antihypertensive effect w/ sympathomimetics. My reduce BP & vascular reactions to dopamine, ephedrine, epinephrine, metaraminol, methoxamine & phenylephrine. May influence renin activity & urinary excretion of vanillylmandelic acid. Reduced hypertensive effect of clonidine IV.

Click to view RiteMED Terazosin detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view RiteMED Terazosin detailed prescribing information

Storage

View RiteMED Terazosin storage conditions for details to ensure optimal shelf-life.

Description

View RiteMED Terazosin description for details of the chemical structure and excipients (inactive components).

Action

View RiteMED Terazosin mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Drugs for Bladder & Prostate Disorders / Other Antihypertensives

ATC Classification

G04CA03 - terazosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

RiteMED Terazosin tab 2 mg

Packing/Price

30's (P803.57/box, P26.79/tab)

Form

RiteMED Terazosin tab 5 mg

Packing/Price

30's (P32.14/tab, P964.29/box)

RiteMED Terazosin

terazosin

Manufacturer:

RiteMED

Distributor:

United Lab